Pharmacotherapeutic strategies for the treatment of anorexia nervosa - too much for one drug?

ABSTRACT:

Introduction

Anorexia nervosa is a severe psychiatric illness and no medication has been approved for its treatment. This lack of biological treatments requires the development of new directions for pharmacological research.

Areas covered

There is modest but emerging evidence that dopamine D2 and serotonin 1A and 2A receptor agonistic and antagonist medication might be beneficial for weight gain, although the underlying mechanisms are uncertain. Improving quality of life including treating comorbid conditions is an additional important outcome measure, but this has not been well researched. Biological and psychological risk factors together with neurobiological alterations during the illness maintain the disorder 's pathophysiology. Neuroscience research can be used to under

SUBMITTER: Frank GKW 

PROVIDER: S-EPMC7491209 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature